Search studies
1 study found
FAIR evaluation
Study types
- observational (1)
- 3D cell cultures (0)
- Brightfield microscopy (0)
- Clinical trial (0)
- Clinical trial NCIT:C71104 (0)
- Drug discovery (0)
- Drug repurposing (0)
- MiRCOVID participants` samples and data for COVIRNA (0)
- PREDI-COVID participants` samples and data for COVIRNA (0)
- PROVID cohort of hospitalized COVID-19 patients (0)
Organisms
Disease
ABI-IBD
Patients with Crohn’s disease or ulcerative colitis diagnosis according to ECCO guidelines and who were prescribed adalimumab or infliximab (original product or biosimilar) were recruited from September 11, 2013 to February 15, 2016. Patients who were not naive to TNF inhibitor therapy or who were treated with corticoids more than 30 mg/day over the last 15 days were excluded.
1
- Types: Observational
